Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tenofovir for HIV Prevention in Injection Drug Users
NCT00119106Phase 3Completed
- Sponsor
- Centers for Disease Control and Prevention
- Start
- Jun 2005
- Primary completion
- Jul 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of tenofovir disoproxil fumarate in human immunodeficiency virus infection (HIV), sponsored by Centers for Disease Control and Prevention. Started Jun 2005; status: completed.
02
Drugs
tenofovir disoproxil fumarate
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT00119106.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00119106.